Taken together, This study reveals the mechanism of MTCH2 deficiency‐induced ferroptosis to inhibit the progression of CRC and supports a potential therapeutic strategy targeting the MTCH2/E2F4/TFRC signaling axis in CRC patients with liver metastasis. Here, E2F4 is linked to colorectal carcinoma.